nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.0415	0.0444	CcSEcCtD
Gabapentin—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0329	0.0353	CcSEcCtD
Gabapentin—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.0269	0.0288	CcSEcCtD
Gabapentin—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0218	CcSEcCtD
Gabapentin—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0212	CcSEcCtD
Gabapentin—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0206	CcSEcCtD
Gabapentin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0192	CcSEcCtD
Gabapentin—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0168	0.018	CcSEcCtD
Gabapentin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0157	CcSEcCtD
Gabapentin—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0151	CcSEcCtD
Gabapentin—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0146	CcSEcCtD
Gabapentin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0131	0.014	CcSEcCtD
Gabapentin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.012	0.0128	CcSEcCtD
Gabapentin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0124	CcSEcCtD
Gabapentin—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0123	CcSEcCtD
Gabapentin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0114	CcSEcCtD
Gabapentin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0109	CcSEcCtD
Gabapentin—Gout—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0108	CcSEcCtD
Gabapentin—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00995	0.0107	CcSEcCtD
Gabapentin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00983	0.0105	CcSEcCtD
Gabapentin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00959	0.0103	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00944	0.143	CbGpPWpGaD
Gabapentin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0086	0.00921	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GRHPR—nephrolithiasis	0.00857	0.13	CbGpPWpGaD
Gabapentin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00851	0.00911	CcSEcCtD
Gabapentin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00851	0.00911	CcSEcCtD
Gabapentin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00838	0.00897	CcSEcCtD
Gabapentin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00841	CcSEcCtD
Gabapentin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00778	0.00833	CcSEcCtD
Gabapentin—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00775	0.00829	CcSEcCtD
Gabapentin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00771	0.00826	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—AGXT—nephrolithiasis	0.00764	0.116	CbGpPWpGaD
Gabapentin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00818	CcSEcCtD
Gabapentin—Injury—Hydrochlorothiazide—nephrolithiasis	0.00743	0.00796	CcSEcCtD
Gabapentin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00737	0.00789	CcSEcCtD
Gabapentin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00779	CcSEcCtD
Gabapentin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00721	0.00772	CcSEcCtD
Gabapentin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00769	CcSEcCtD
Gabapentin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00769	CcSEcCtD
Gabapentin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00709	0.00759	CcSEcCtD
Gabapentin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00753	CcSEcCtD
Gabapentin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00735	CcSEcCtD
Gabapentin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00683	0.00732	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00678	0.00726	CcSEcCtD
Gabapentin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00673	0.0072	CcSEcCtD
Gabapentin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00673	0.0072	CcSEcCtD
Gabapentin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00706	CcSEcCtD
Gabapentin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00693	CcSEcCtD
Gabapentin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00688	CcSEcCtD
Gabapentin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00686	CcSEcCtD
Gabapentin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00676	CcSEcCtD
Gabapentin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00671	CcSEcCtD
Gabapentin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00661	CcSEcCtD
Gabapentin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00605	0.00648	CcSEcCtD
Gabapentin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00645	CcSEcCtD
Gabapentin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00632	CcSEcCtD
Gabapentin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00632	CcSEcCtD
Gabapentin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0062	CcSEcCtD
Gabapentin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00575	0.00616	CcSEcCtD
Gabapentin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00591	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00588	CcSEcCtD
Gabapentin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00584	CcSEcCtD
Gabapentin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00582	CcSEcCtD
Gabapentin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00577	CcSEcCtD
Gabapentin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00538	0.00576	CcSEcCtD
Gabapentin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00533	0.0057	CcSEcCtD
Gabapentin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00567	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00559	CcSEcCtD
Gabapentin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00556	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00518	0.0784	CbGpPWpGaD
Gabapentin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00554	CcSEcCtD
Gabapentin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00553	CcSEcCtD
Gabapentin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00553	CcSEcCtD
Gabapentin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0055	CcSEcCtD
Gabapentin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00548	CcSEcCtD
Gabapentin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00548	CcSEcCtD
Gabapentin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00541	CcSEcCtD
Gabapentin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00538	CcSEcCtD
Gabapentin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00532	CcSEcCtD
Gabapentin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00529	CcSEcCtD
Gabapentin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00515	CcSEcCtD
Gabapentin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00507	CcSEcCtD
Gabapentin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00506	CcSEcCtD
Gabapentin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00504	CcSEcCtD
Gabapentin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00502	CcSEcCtD
Gabapentin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00499	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00461	0.0698	CbGpPWpGaD
Gabapentin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00488	CcSEcCtD
Gabapentin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00479	CcSEcCtD
Gabapentin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00472	CcSEcCtD
Gabapentin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00447	CcSEcCtD
Gabapentin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00441	CcSEcCtD
Gabapentin—CACNA2D2—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00407	0.0616	CbGpPWpGaD
Gabapentin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00434	CcSEcCtD
Gabapentin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00432	CcSEcCtD
Gabapentin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00432	CcSEcCtD
Gabapentin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.004	0.00428	CcSEcCtD
Gabapentin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00426	CcSEcCtD
Gabapentin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00424	CcSEcCtD
Gabapentin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00415	CcSEcCtD
Gabapentin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00413	CcSEcCtD
Gabapentin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00409	CcSEcCtD
Gabapentin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00407	CcSEcCtD
Gabapentin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00405	CcSEcCtD
Gabapentin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00403	CcSEcCtD
Gabapentin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00397	CcSEcCtD
Gabapentin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00396	CcSEcCtD
Gabapentin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00395	CcSEcCtD
Gabapentin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00394	CcSEcCtD
Gabapentin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00389	CcSEcCtD
Gabapentin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00387	CcSEcCtD
Gabapentin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00385	CcSEcCtD
Gabapentin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00375	CcSEcCtD
Gabapentin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00375	CcSEcCtD
Gabapentin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00375	CcSEcCtD
Gabapentin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00374	CcSEcCtD
Gabapentin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00371	CcSEcCtD
Gabapentin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00367	CcSEcCtD
Gabapentin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00363	CcSEcCtD
Gabapentin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0036	CcSEcCtD
Gabapentin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0036	CcSEcCtD
Gabapentin—Shock—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00354	CcSEcCtD
Gabapentin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00352	CcSEcCtD
Gabapentin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00351	CcSEcCtD
Gabapentin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00348	CcSEcCtD
Gabapentin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00343	CcSEcCtD
Gabapentin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00336	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00308	0.0467	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00328	CcSEcCtD
Gabapentin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00325	CcSEcCtD
Gabapentin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00323	CcSEcCtD
Gabapentin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00321	CcSEcCtD
Gabapentin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0032	CcSEcCtD
Gabapentin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00317	CcSEcCtD
Gabapentin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00313	CcSEcCtD
Gabapentin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0031	CcSEcCtD
Gabapentin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00308	CcSEcCtD
Gabapentin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00308	CcSEcCtD
Gabapentin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00296	CcSEcCtD
Gabapentin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00294	CcSEcCtD
Gabapentin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00286	CcSEcCtD
Gabapentin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00284	CcSEcCtD
Gabapentin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00284	CcSEcCtD
Gabapentin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00265	CcSEcCtD
Gabapentin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00258	CcSEcCtD
Gabapentin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00254	CcSEcCtD
Gabapentin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00246	CcSEcCtD
Gabapentin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00238	CcSEcCtD
Gabapentin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00229	CcSEcCtD
Gabapentin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00227	CcSEcCtD
Gabapentin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00227	CcSEcCtD
Gabapentin—Headache—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00225	CcSEcCtD
Gabapentin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.002	0.00214	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GRHPR—nephrolithiasis	0.00157	0.0238	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGXT—nephrolithiasis	0.0014	0.0212	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0014	0.0211	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0012	0.0181	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APRT—nephrolithiasis	0.00119	0.0181	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC26A1—nephrolithiasis	0.00119	0.0181	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00105	0.016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RGS14—nephrolithiasis	0.000958	0.0145	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GRHPR—nephrolithiasis	0.000954	0.0144	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000912	0.0138	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGXT—nephrolithiasis	0.00085	0.0129	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AQP1—nephrolithiasis	0.00085	0.0129	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTH—nephrolithiasis	0.000834	0.0126	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CHRM3—nephrolithiasis	0.000769	0.0116	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC26A1—nephrolithiasis	0.000723	0.0109	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APRT—nephrolithiasis	0.000723	0.0109	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000713	0.0108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADCY10—nephrolithiasis	0.000666	0.0101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—DGKH—nephrolithiasis	0.000647	0.00979	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RGS14—nephrolithiasis	0.000566	0.00857	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000515	0.0078	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AQP1—nephrolithiasis	0.000515	0.00779	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTH—nephrolithiasis	0.000471	0.00713	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000468	0.00708	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CHRM3—nephrolithiasis	0.000466	0.00705	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTH—nephrolithiasis	0.000428	0.00648	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000382	0.00579	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DGKH—nephrolithiasis	0.000382	0.00579	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CHRM3—nephrolithiasis	0.000276	0.00418	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTH—nephrolithiasis	0.000253	0.00383	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—nephrolithiasis	0.000127	0.00192	CbGpPWpGaD
